icad inc (ICAD) - Cash Flow Conversion Efficiency

Latest as of March 2025: 0.002x

Based on the latest financial reports, icad inc (ICAD) has a cash flow conversion efficiency ratio of 0.002x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($60.00K) by net assets ($30.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ICAD net asset quality index to measure how much of total assets are equity-financed.

icad inc - Cash Flow Conversion Efficiency Trend (1988–2024)

This chart illustrates how icad inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ICAD operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

icad inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of icad inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Viva Leisure Ltd
AU:VVA
0.366x
An Phat Plastic and Green Environment JSC
VN:AAA
0.021x
Bogota Financial Corp
NASDAQ:BSBK
0.002x
Bixolon Co. Ltd
KQ:093190
0.047x
Aemetis Inc
NASDAQ:AMTX
0.033x
Lhyfe SA
PA:LHYFE
-0.190x
AS HARJU ELEKTER EO 063
F:HD8
0.034x
Iljin Power Co. Ltd
KQ:094820
0.032x

Annual Cash Flow Conversion Efficiency for icad inc (1988–2024)

The table below shows the annual cash flow conversion efficiency of icad inc from 1988 to 2024. For the full company profile with market capitalisation and key ratios, see icad inc market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $28.68 Million $-3.94 Million -0.138x +7.41%
2023-12-31 $33.42 Million $-4.96 Million -0.149x +59.46%
2022-12-31 $34.90 Million $-12.79 Million -0.366x -81.18%
2021-12-31 $46.52 Million $-9.41 Million -0.202x +11.62%
2020-12-31 $30.52 Million $-6.99 Million -0.229x +83.67%
2019-12-31 $5.07 Million $-7.11 Million -1.401x -149.93%
2018-12-31 $6.90 Million $-3.87 Million -0.561x -9.11%
2017-12-31 $14.28 Million $-7.34 Million -0.514x -134.90%
2016-12-31 $25.04 Million $-5.48 Million -0.219x -277.07%
2015-12-31 $32.75 Million $-1.90 Million -0.058x -213.69%
2014-12-31 $62.78 Million $3.20 Million 0.051x +176.62%
2013-12-31 $21.38 Million $-1.42 Million -0.067x +56.16%
2012-12-31 $27.66 Million $-4.20 Million -0.152x +45.98%
2011-12-31 $36.05 Million $-10.14 Million -0.281x -10032.78%
2010-12-31 $73.21 Million $207.33K 0.003x -94.55%
2009-12-31 $66.31 Million $3.44 Million 0.052x -64.80%
2008-12-31 $66.29 Million $9.78 Million 0.147x +1153.97%
2007-12-31 $48.85 Million $574.57K 0.012x +112.79%
2006-12-31 $47.97 Million $-4.41 Million -0.092x -273.93%
2005-12-31 $52.73 Million $-1.30 Million -0.025x +28.16%
2004-12-31 $56.97 Million $-1.95 Million -0.034x +64.87%
2003-12-31 $47.90 Million $-4.67 Million -0.097x +7.33%
2002-12-31 $21.46 Million $-2.26 Million -0.105x +84.43%
2001-12-31 $2.04 Million $-1.38 Million -0.675x -241.10%
2000-12-31 $2.90 Million $-574.33K -0.198x +40.63%
1999-12-31 $3.00 Million $-1.00 Million -0.333x +63.49%
1998-12-31 $2.30 Million $-2.10 Million -0.913x -172.19%
1997-12-31 $3.40 Million $4.30 Million 1.265x +618.53%
1996-12-31 $4.10 Million $-1.00 Million -0.244x -72.76%
1995-12-31 $8.50 Million $-1.20 Million -0.141x -374.29%
1994-12-31 $13.60 Million $700.00K 0.051x -85.38%
1993-12-31 $12.50 Million $4.40 Million 0.352x +396.71%
1992-12-31 $12.70 Million $900.00K 0.071x +216.22%
1991-12-31 $8.20 Million $-500.00K -0.061x +83.36%
1990-12-31 $13.10 Million $-4.80 Million -0.366x -131.81%
1988-12-31 $7.90 Million $9.10 Million 1.152x --

About icad inc

NASDAQ:ICAD USA Medical Devices
Market Cap
$106.31 Million
Market Cap Rank
#18902 Global
#4325 in USA
Share Price
$3.87
Change (1 day)
+0.00%
52-Week Range
$3.87 - $3.87
All Time High
$21.22
About

iCAD, Inc. provides AI-powered cancer detection solutions in the United States. The company's ProFound Breast Health Suite offers solutions for"breast"cancer detection, breast density assessment, one- or two-year breast cancer risk evaluation, and cardiovascular risk assessment related to elevated levels of breast arterial calcifications; and enables medical providers and professionals to accurat… Read more